The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Supply Chain Strategies & Solutions Article
Dangerous Infusion Errors Top ECRI Institute's Annual Health Technology Hazards List
The safe use of health technology—from infusion pumps to complex imaging systems—requires that healthcare facilities recognize the possibility of d
Supply Chain Strategies & Solutions Article
From the Basement to the Boardroom
The shift to bundled payments in health care continues to push the supply chain to a more central position in the overall operations and capa
Supply Chain Strategies & Solutions Article
How a Community Hospital Improved Heart Attack Outcomes while Reducing Costs to Outperform Most Hospitals in the Country
This article is from the March/April 2017 issue of the AHRMM member-only magazine, Supply Chain Strategies & Solutions. At St.
Supply Chain Strategies & Solutions Article
Bundled Payments Reshape Healthcare and the Supply Chain
Bundled payments provide a single payment for a defined episode of care that is shared among the caregivers involved in the delivery of care, with
Case Studies
Chesapeake Regional Medical Center Boosts Supply Chain Visibility for More Efficient and Effective Inventory Management and Patient Billing
This is an executive summary of the case study published in the
Case Studies
CHRISTUS Santa Rosa Improves Quality and Efficiency of Lab Test Procedures for Lower Costs and Enhanced Patient Care Delivery
This is an executive summary of the case study published in the